Open AccessP23: Elvitegravir/cobicistat/emtricitabine/tenofovir DF demonstrates durable efficacy and safety versus efavirenz/emtricitabine/tenofovir DF at Week 144
Author(s) -
Hawkins Trevor,
Campo Rafael,
David Wohl,
Cohen Cal,
Joel Gallant,
M Falcone Anthony,
Sax Paul,
Zolopa Andrew,
Liu Hui C,
White Kirsten L,
Rhee Martin S,
Szwarcberg Javier
Publication year - 2014
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.7448/ias.17.2.19132
Subject(s) - elvitegravir , efavirenz , medicine , emtricitabine , cobicistat , tenofovir , human immunodeficiency virus (hiv) , pharmacology , virology , antiretroviral therapy , viral load
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom